Real‐world risk of cardiovascular diseases in patients with type 2 diabetes associated with sodium–glucose cotransporter 2 inhibitors in comparison with metformin: A propensity score‐matched model analysis in Japan
Journal of Diabetes Investigation · 2023
DOI: 10.1111/jdi.14062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2023. Verfasst von Takeshi Horii und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Faculty of Pharmacy, Musashino University, Tokyo, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Metformin, Cardiovascular Diseases, Sodium-Glucose Transporter 2 Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
We aimed to compare the effects of cardiovascular disease risk in Japanese patients with type 2 diabetes on sodium–glucose cotransporter 2 inhibitors (SGLT2Is) or metformin. This retrospective, real‐world cohort study was carried out using a claims database and propensity score matching; 58,402 eligible patients (29,201 per group) were included. The outcomes included nonfatal myocardial infarction, angina pectoris, nonfatal stroke, hospitalization for heart failure and composite end‐points. The hazard ratio (HR) for the composite end‐point was 0.79, which was lower for SGLT2Is than for metformin. For male patients (HR 0.76), patients aged
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Faculty of Pharmacy, Musashino University, Tokyo, Japan.
- Department of Endocrinology and Diabetes, School of Medicine, Saitama Medical University, Saitama, Japan.
ORCID-Profile: Takeshi Horii, Yoichi Oikawa, Akira Shimada
Zitieren
APA
Horii, T., Oikawa, Y., Shimada, A., & Mihara, K. (2023). Real‐world risk of cardiovascular diseases in patients with type 2 diabetes associated with sodium–glucose cotransporter 2 inhibitors in comparison with metformin: A propensity score‐matched model analysis in Japan. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14062
Vancouver
Horii T, Oikawa Y, Shimada A, Mihara K. Real‐world risk of cardiovascular diseases in patients with type 2 diabetes associated with sodium–glucose cotransporter 2 inhibitors in comparison with metformin: A propensity score‐matched model analysis in Japan. Journal of Diabetes Investigation. 2023. doi:10.1111/jdi.14062
BibTeX
@article{Horii2023,
author = {Horii, Takeshi and Oikawa, Yoichi and Shimada, Akira and Mihara, Kiyoshi},
title = {Real‐world risk of cardiovascular diseases in patients with type 2 diabetes associated with sodium–glucose cotransporter 2 inhibitors in comparison with metformin: A propensity score‐matched model analysis in Japan},
journal = {Journal of Diabetes Investigation},
year = {2023},
doi = {10.1111/jdi.14062}
}
EUVIMED